D.E. Shaw & Co’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Sell |
647,629
-302,097
| -32% | -$320K | ﹤0.01% | 2401 |
|
|
2025
Q1 | $1.04M | Sell |
949,726
-74,562
| -7% | -$81.3K | ﹤0.01% | 2158 |
|
|
2024
Q4 | $1.55M | Sell |
1,024,288
-16,189
| -2% | -$24.4K | ﹤0.01% | 1930 |
|
|
2024
Q3 | $1.55M | Buy |
1,040,477
+20,849
| +2% | +$31.1K | ﹤0.01% | 1936 |
|
|
2024
Q2 | $1.65M | Buy |
1,019,628
+298,993
| +41% | +$484K | ﹤0.01% | 1930 |
|
|
2024
Q1 | $1.23M | Buy |
720,635
+472,130
| +190% | +$803K | ﹤0.01% | 2009 |
|
|
2023
Q4 | $770K | Buy |
248,505
+219,707
| +763% | +$681K | ﹤0.01% | 2193 |
|
|
2023
Q3 | $177K | Sell |
28,798
-32,473
| -53% | -$199K | ﹤0.01% | 2607 |
|
|
2023
Q2 | $384K | Buy |
61,271
+6,414
| +12% | +$40.2K | ﹤0.01% | 2422 |
|
|
2023
Q1 | $262K | Buy |
54,857
+38,890
| +244% | +$186K | ﹤0.01% | 2723 |
|
|
2022
Q4 | $139K | Buy |
+15,967
| New | +$139K | ﹤0.01% | 3099 |
|
|
2021
Q1 | – | Sell |
-28,736
| Closed | -$1.77M | – | 3136 |
|
|
2020
Q4 | $1.77M | Buy |
+28,736
| New | +$1.77M | ﹤0.01% | 1782 |
|